Ayesha Lall
Child & Adolescent Psychiatry · Gainesville, FLNPI 1942221031
Payments from drug & device makers
Across 346 payments — averaging $10,252 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1.2M
- Eli Lilly$673K
- Janssen Research & Development, LLC$494K
- Eisai Inc.$426K
- Biogen$337K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$164K
- plus $289K from 18 others
Across 15 payments — averaging $817.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biogen$6K
- Eli Lilly$5K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$2K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 116 | $1,164,463 |
| Eli Lilly | 18 | $673,265 |
| Janssen Research & Development, LLC | 55 | $494,102 |
| Eisai Inc. | 40 | $425,928 |
| Biogen | 5 | $336,825 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 6 | $163,532 |
| Acadia Pharmaceuticals Inc | 22 | $117,037 |
| E.r. Squibb & Sons, L.L.C. | 3 | $53,015 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 17 | $38,391 |
| Genentech, Inc. | 7 | $24,310 |
| Corium, LLC | 4 | $21,500 |
| Boehringer Ingelheim | 10 | $12,864 |
| Sumitomo Pharma America, Inc. | 21 | $7,504 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $5,750 |
| Boehringer Ingelheim RCV GmbH & Co KG | 3 | $4,904 |
| Supernus Pharmaceuticals, Inc. | 3 | $1,801 |
| Pfizer | 1 | $1,500 |
| Otsuka America Pharmaceutical, Inc. | 4 | $173 |
| Medtronic | 1 | $66 |
| Teva Pharmaceuticals USA, Inc. | 1 | $60 |
| Neuronetics, Inc. | 1 | $59 |
| Shire North American Group Inc | 3 | $52 |
| Lundbeck LLC | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $24 |
How this compares
$3,547,165 in reported general payments places this provider in the 95th percentile of 206 child & adolescent psychiatry providers in Florida.
See all child & adolescent psychiatry providers in Florida →
Other child & adolescent psychiatry in Gainesville
- Elias SarkisGainesville$4M
- Anand PatelGainesville$627K
- Muhammad SajidGainesville$5K
- Amparo Benitez-BroomeGainesville$2K
- Americo PadillaMiami$1.6M
- Rosa Negron MunozLakeland$726K
- Alexander PushkaHollywood$601K
- Mark BarnettMiami Beach$290K
- Craig KuninsGulfport$265K
- Jose AlvarezMiami$229K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.